Afuco™ Anti-MET ADCC Therapeutic Antibody (Onartuzumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant Human Antibody (Onartuzumab (OA5D5.v2)) is capable of binding to MET, expressed in CHO.
| Supplier | Creative Biolabs |
|---|---|
| Product # | PABZ-155 |
| Pricing | Inquiry |
| Host | Humanized |
| Target | MET |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | ELISA, Neut |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |